Viewing nowARB-S Tablets 20 mg (Olmesartan Medoxomil)
Olmesartan Medoxomil 20mg
Tablet · Prescription medication
Samjin Pharmaceutical Co., Ltd.

MFDS item code 201100813 · Approved 2011.02.21 · Insurance code 647803490
Treatment of essential hypertension
Essential hypertension plays an important role in controlling blood pressure within the normal range and reducing the risk of cardiovascular diseases. This medication lowers blood pressure and relieves the burden on the heart, helping to prevent complications. It is crucial to manage blood pressure stably through consistent use. Furthermore, it is more effective when used along with improvements in the patient's lifestyle habits. It is used in the treatment of essential hypertension.
<Adults> The recommended initial dose is 10mg once daily, administered with or without food. If blood pressure is not adequately controlled at this dose, increase to 20mg once daily. If further blood pressure reduction is required, the dose may be increased to a maximum of 40mg daily. The blood pressure-lowering effect appears within 2 weeks after starting treatment, with the maximum effect occurring at approximately 8 weeks. If blood pressure is not controlled with this drug alone, it may be administered in combination with a thiazide diuretic such as hydrochlorothiazide. To improve adherence, it is recommended that the drug be taken at the same time each day, if possible (e.g., in the morning). For patients who may have intravascular volume depletion (e.g., patients taking diuretics, particularly those with renal impairment), it is recommended to initiate treatment at a low dose while closely monitoring their condition. <Elderly patients> No dose adjustment is necessary when administering this drug to patients aged 65 years or older. Although no overall differences in efficacy or safety have been observed between elderly and younger patients, a more sensitive response in some elderly patients cannot be ruled out. <Patients with renal impairment> The maximum dose for patients with mild to moderate renal impairment (creatinine clearance 20-60mL/min) is 20mg once daily. <Patients with hepatic impairment> No dose adjustment is necessary for patients with mild hepatic impairment. The recommended initial dose for patients with moderate hepatic impairment is 10mg once daily, and the dose may be increased to a maximum of 20mg daily. Since there is no experience with use in patients with severe hepatic impairment, administration of this drug is not recommended.
Safety and efficacy in children have not been established.
This drug can cause serious harm or death to the fetus and newborn if taken during the second and third trimesters of pregnancy, so it should be discontinued immediately if pregnancy is confirmed. People who are allergic to any of the ingredients in this drug, pregnant or breastfeeding women, patients undergoing kidney dialysis, patients with severe liver dysfunction, patients with bile duct obstruction, and certain genetically lactose intolerant patients should not take this drug. Patients with reduced blood volume or sodium may experience hypotension, so it is important to check their condition before taking this drug and take appropriate measures immediately if symptoms of hypotension occur. Patients with severe heart failure or impaired kidney function may experience changes in kidney function, so regular blood tests should be performed to monitor kidney status. During treatment with this drug, serum potassium levels may increase, so patients with heart disease or kidney disease should regularly check their potassium levels. Dizziness may occur, so it is advisable to avoid hazardous operations such as working at heights or driving vehicles. Various adverse reactions have been reported with this drug, mainly dizziness, headache, indigestion, muscle pain, rash, and rarely angioedema or liver function abnormalities. If gastrointestinal symptoms such as chronic diarrhea or weight loss persist, stop taking this drug and consult a doctor. When used with other antihypertensives, potassium-sparing diuretics, lithium drugs, and non-steroidal anti-inflammatory drugs, drug interactions may occur, so it is essential to inform the doctor or pharmacist. Pregnant women should refrain from using this drug due to risks to the fetus, and breastfeeding mothers should carefully decide whether to take it as it may cause adverse reactions in infants. The safety of this drug has not been established for children, so caution is needed in its use. In elderly patients, the concentration of the drug may increase in the body, so dose adjustment and monitoring of condition are important. In case of overdose, symptoms such as low blood pressure, palpitations, and bradycardia may occur, and appropriate treatment should be received immediately at a medical institution. This drug has not been reported to have carcinogenic or genotoxic effects with long-term use, but in some cell experiments, the possibility of chromosomal mutations has been observed, so caution is needed with long-term use.
Not everyone experiences these, and they can vary from person to person.
This drug may be sensitive to air and moisture, so it should be stored in a tightly sealed container. It is advisable to maintain a storage temperature between 1 degree and 25 degrees Celsius. Storing it this way can help preserve the drug's effectiveness and safety for a long time.
White round film-coated tablets
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowOlmesartan Medoxomil 20mg
Tablet · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Olmesartan Medoxomil 10mg
Tablet · Prescription medication
JW Pharmaceutical Corporation

Olmesartan Medoxomil 40mg
Tablet · Prescription medication
JW Pharmaceutical Corp.

Olmesartan Medoxomil 20mg
Tablet · Prescription medication
JW Pharmaceutical Corporation

Olmesartan Medoxomil 20mg
Tablet · Prescription medication
Dongkuk Pharmaceutical Co., Ltd.

Olmesartan Medoxomil 10mg
Tablet · Prescription medication
DongKook Pharmaceutical Co., Ltd.

Olmesartan Medoxomil 20mg
Tablet · Prescription medication
Hana Pharmaceutical Co., Ltd.

Olmesartan Medoxomil 10mg
Tablet · Prescription medication
Samjin Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.